Sfoglia per Rivista VACCINE
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal?
2021-01-01 Marchi, Serena; Remarque, Edmond J.; Viviani, Simonetta; Rizzo, Caterina; Monteverde Spencer, Geraldo Tadinho; Coluccio, Rosa; Montomoli, Emanuele; Trombetta, Claudia Maria
Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations
2019-01-01 Valentini, S.; Santoro, G.; Baffetta, F.; Franceschi, S.; Paludi, M.; Brandini, E.; Gherardini, L.; Serruto, D.; Capecchi, B.
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines
2005-01-01 Oxford, J. S.; Manuguerra, C.; Kistner, O.; Linde, A.; Kunze, M.; Lange, W.; Schweiger, B.; Spala, G.; REBELO DE ANDRADE, H.; PREZ BREA, P. R.; Beytout, J.; Brydak, L.; CARAFFA DE STEFANO, D.; Hungnes, O.; Kyncl, J.; Montomoli, E.; GIL DE MIGUEL, A.; Vranckx, R.; Osterhaus, A.
The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: an Italian phenomenon?
2022-01-01 Bifulco, M; Di Zazzo, E; Pisanti, S; Martini, M; Orsini, D
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies
2012-01-01 Faenzi, Elisa; Zedda, Luisanna; Bardelli, Monia; Spensieri, Fabiana; Borgogni, Erica; Volpini, Gianfranco; Buricchi, Francesca; Laghi Pasini, Franco; Capecchi, Pier Leopoldo; Montanaro, Fabio; Belli, Riccardo; Lattanzi, Maria; Piccirella, Simona; Montomoli, Emanuele; Ahmed, Syed Soahail; Rappuoli, Rino; Del Giudice, Giuseppe; Finco, Oretta; Castellino, Flora; Galli, Grazia
Oral priming of mice by recombinant spores of Bacillus subtilis.
2004-01-01 Ciabattini, A; Parigi, R; Isticato, R; Oggioni, Mr; Pozzi, Gianni
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation
2015-01-01 Prota, Gennaro; Christensen, Dennis; Andersen, Peter; Medaglini, Donata; Ciabattini, Annalisa
Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations
2015-01-01 Eidem, Synnøve; Tete, Sarah M.; Jul-Larsen, Åsne; Hoschler, Katja; Montomoli, Emanuele; Brokstad, Karl A.; Cox, Rebecca J.
Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination
2023-01-01 Chiavenna, Chiara; Leone, Laura P.; Melegaro, Alessia; Rotesi, Tiziano; Bokemper, Scott E.; Paintsil, Elliott E.; Malik, Amyn A.; Huber, Gregory A.; Omer, Saad B.; Cucciniello, Maria; Pin, Paolo
A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses
2018-01-01 van de Witte, Serge; Nauta, Jos; Montomoli, Emanuele; Weckx, Jos
Potential of DNA vaccines delivered by influenza virosomes
2000-01-01 Cusi, M. G.; Gluck, R.
Pre-emptive vaccination against pandemic influenza virus
2007-01-01 Montomoli, E.; Manini, I.
Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the italian population
1999-01-01 Bergamini, M.; Comodo, N.; Gasparini, R.; Gabutti, G.; Fabrizi, P.; Severini, R.; Ajello, F.; Bonanni, P.; Castagnari, L.; Cocchioni, M.; Della Pietra, P.; Fragapane, E.; Grilli, A.; Liberatore, S.; Lo Nostro, A.; Moiraghi Ruggenini, A.; Pellegrini, M. G.; Pozzi, T.; Tarsitani, G.; Zotti, C.; Crovari, P.
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses
2009-01-01 Alberini, Isabella; DEL TORDELLO, Elena; Fasolo, Alba; Temperton, Nigel; Galli, Grazia; Gentile, Chiara; Montomoli, Emanuele; Hilbert, ANNE K.; Banzhoff, Angelika; DEL GIUDICE, Giuseppe; Donnelly, John; Rappuoli, Rino; Capecchi, Barbara
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza
2017-01-01 Rondy, M.; Launay, O.; Castilla, J.; Costanzo, S.; Puig-Barbera, J.; Gefenaite, G.; Larrauri, A.; Rizzo, C.; Pitigoi, D.; Syrjanen, R. K.; Machado, A.; Kurecic Filipovic, S.; Krisztina Horvath, J.; Paradowska-Stankiewicz, I.; Marbus, S.; Moren, A.; InNHOVE/I-MOVE+working, Group; Manini, I.; Montomoli, E.
The role of the vaccines industry in Mission Grand Convergence
2017-01-01 Almond, J.; Medaglini, D.
Safety, tolerability and immunogenicity of a mammalian cell culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial
2009-01-01 Groth, N.; Montomoli, E.; Gentile, C.; Manini, I.; Bugarini, R.; Podda, A.
Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine
1987-01-01 Valensin, P. E.; Rossolini, G. M.; Cusi, M. G.; Zanchi, A.; Cellesi, C.; Rossolini, A.
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
2007-01-01 Alfonsi, V.; Montomoli, E.; Manini, I.; Alberini, I.; Gentile, C.; Rota, M. C.; CIOFI DEGLI ATTI, M. L.
The European effort towards the development of mucosal vaccines for poverty-related diseases.
2009-01-01 Medaglini, Donata; Olesen, Of; Rappuoli, R.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Measles immunity over two decades in two large Italian Regions: How far is the elimination goal? | 1-gen-2021 | Marchi, Serena; Remarque, Edmond J.; Viviani, Simonetta; Rizzo, Caterina; Monteverde Spencer, Geraldo Tadinho; Coluccio, Rosa; Montomoli, Emanuele; Trombetta, Claudia Maria | - | |
| Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations | 1-gen-2019 | Valentini, S.; Santoro, G.; Baffetta, F.; Franceschi, S.; Paludi, M.; Brandini, E.; Gherardini, L.; Serruto, D.; Capecchi, B. | - | |
| A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines | 1-gen-2005 | Oxford, J. S.; Manuguerra, C.; Kistner, O.; Linde, A.; Kunze, M.; Lange, W.; Schweiger, B.; Spala, G.; REBELO DE ANDRADE, H.; PREZ BREA, P. R.; Beytout, J.; Brydak, L.; CARAFFA DE STEFANO, D.; Hungnes, O.; Kyncl, J.; Montomoli, E.; GIL DE MIGUEL, A.; Vranckx, R.; Osterhaus, A. | - | |
| The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: an Italian phenomenon? | 1-gen-2022 | Bifulco, M; Di Zazzo, E; Pisanti, S; Martini, M; Orsini, D | - | |
| One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies | 1-gen-2012 | Faenzi, Elisa; Zedda, Luisanna; Bardelli, Monia; Spensieri, Fabiana; Borgogni, Erica; Volpini, Gianfranco; Buricchi, Francesca; Laghi Pasini, Franco; Capecchi, Pier Leopoldo; Montanaro, Fabio; Belli, Riccardo; Lattanzi, Maria; Piccirella, Simona; Montomoli, Emanuele; Ahmed, Syed Soahail; Rappuoli, Rino; Del Giudice, Giuseppe; Finco, Oretta; Castellino, Flora; Galli, Grazia | - | |
| Oral priming of mice by recombinant spores of Bacillus subtilis. | 1-gen-2004 | Ciabattini, A; Parigi, R; Isticato, R; Oggioni, Mr; Pozzi, Gianni | - | |
| Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation | 1-gen-2015 | Prota, Gennaro; Christensen, Dennis; Andersen, Peter; Medaglini, Donata; Ciabattini, Annalisa | - | |
| Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations | 1-gen-2015 | Eidem, Synnøve; Tete, Sarah M.; Jul-Larsen, Åsne; Hoschler, Katja; Montomoli, Emanuele; Brokstad, Karl A.; Cox, Rebecca J. | - | |
| Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination | 1-gen-2023 | Chiavenna, Chiara; Leone, Laura P.; Melegaro, Alessia; Rotesi, Tiziano; Bokemper, Scott E.; Paintsil, Elliott E.; Malik, Amyn A.; Huber, Gregory A.; Omer, Saad B.; Cucciniello, Maria; Pin, Paolo | - | |
| A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses | 1-gen-2018 | van de Witte, Serge; Nauta, Jos; Montomoli, Emanuele; Weckx, Jos | - | |
| Potential of DNA vaccines delivered by influenza virosomes | 1-gen-2000 | Cusi, M. G.; Gluck, R. | - | |
| Pre-emptive vaccination against pandemic influenza virus | 1-gen-2007 | Montomoli, E.; Manini, I. | - | |
| Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the italian population | 1-gen-1999 | Bergamini, M.; Comodo, N.; Gasparini, R.; Gabutti, G.; Fabrizi, P.; Severini, R.; Ajello, F.; Bonanni, P.; Castagnari, L.; Cocchioni, M.; Della Pietra, P.; Fragapane, E.; Grilli, A.; Liberatore, S.; Lo Nostro, A.; Moiraghi Ruggenini, A.; Pellegrini, M. G.; Pozzi, T.; Tarsitani, G.; Zotti, C.; Crovari, P. | - | |
| Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses | 1-gen-2009 | Alberini, Isabella; DEL TORDELLO, Elena; Fasolo, Alba; Temperton, Nigel; Galli, Grazia; Gentile, Chiara; Montomoli, Emanuele; Hilbert, ANNE K.; Banzhoff, Angelika; DEL GIUDICE, Giuseppe; Donnelly, John; Rappuoli, Rino; Capecchi, Barbara | - | |
| Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza | 1-gen-2017 | Rondy, M.; Launay, O.; Castilla, J.; Costanzo, S.; Puig-Barbera, J.; Gefenaite, G.; Larrauri, A.; Rizzo, C.; Pitigoi, D.; Syrjanen, R. K.; Machado, A.; Kurecic Filipovic, S.; Krisztina Horvath, J.; Paradowska-Stankiewicz, I.; Marbus, S.; Moren, A.; InNHOVE/I-MOVE+working, Group; Manini, I.; Montomoli, E. | - | |
| The role of the vaccines industry in Mission Grand Convergence | 1-gen-2017 | Almond, J.; Medaglini, D. | - | |
| Safety, tolerability and immunogenicity of a mammalian cell culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial | 1-gen-2009 | Groth, N.; Montomoli, E.; Gentile, C.; Manini, I.; Bugarini, R.; Podda, A. | - | |
| Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine | 1-gen-1987 | Valensin, P. E.; Rossolini, G. M.; Cusi, M. G.; Zanchi, A.; Cellesi, C.; Rossolini, A. | - | |
| Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? | 1-gen-2007 | Alfonsi, V.; Montomoli, E.; Manini, I.; Alberini, I.; Gentile, C.; Rota, M. C.; CIOFI DEGLI ATTI, M. L. | - | |
| The European effort towards the development of mucosal vaccines for poverty-related diseases. | 1-gen-2009 | Medaglini, Donata; Olesen, Of; Rappuoli, R. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile